HEALTHCARING CONVERSATIONS FOR CLINICAL RESEARCH
Live / Registered — Registered (as of 09 Jan 2024)
What this means for you
Registered since 09 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88448248
- Registration number
- 7269845
- Mark type
- Stylized text
- Filed
- 28 May 2019
- Published for opposition
- 22 Sept 2020
- Registered
- 09 Jan 2024
- Attorney of record
- Cheryl L. Foytlin
Goods and services
- Class 035 — Advertising and business services: Providing information to healthcare professionals regarding recruiting patients for participation in clinical trials and optimizing patient engagement and experiences in the clinical trial process
- Class 042 — Scientific and technological services: Providing information in the field of clinical trials and studies for human pharmaceuticals; providing information regarding clinical trials to healthcare professionals regarding how to optimize patient engagement and experiences in the clinical trial process
- Class 044 — Medical, beauty and agricultural services: Providing healthcare information to healthcare professionals regarding how to optimize patient engagement and experiences in the clinical trial process
Owner
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
Prosecution history
- 09 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 09 Jan 2024 — REGISTERED-PRINCIPAL REGISTER
- 05 Dec 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Dec 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Nov 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Nov 2023 — USE AMENDMENT FILED
- 16 Nov 2023 — TEAS STATEMENT OF USE RECEIVED
- 18 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 May 2023 — SOU EXTENSION 5 GRANTED
- 15 May 2023 — SOU EXTENSION 5 FILED
- 17 May 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 May 2023 — SOU TEAS EXTENSION RECEIVED
- 17 Nov 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Nov 2022 — SOU EXTENSION 4 GRANTED
- 15 Nov 2022 — SOU EXTENSION 4 FILED